Update on vedolizumab in IBD: What have we learned?
Earn CME for related activities:
https://www.naccme.com/ias
New findings, new techniques, and recent efforts in research and discovery have changed the way physicians treat their patients – taking a more individualized approach. Mastering Clinical Challenges and Emerging Therapies in IBD, held in Chicago, Illinois on July 23, 2016 provided important clinical updates in the management of patients with inflammatory bowel disease.
In this presentation, Dr. David T. Rubin presents an update on the use of vedolizumab for inflammatory bowel disease (IBD).
© 2016 Imedex, LLC.
Видео Update on vedolizumab in IBD: What have we learned? канала ImedexCME
https://www.naccme.com/ias
New findings, new techniques, and recent efforts in research and discovery have changed the way physicians treat their patients – taking a more individualized approach. Mastering Clinical Challenges and Emerging Therapies in IBD, held in Chicago, Illinois on July 23, 2016 provided important clinical updates in the management of patients with inflammatory bowel disease.
In this presentation, Dr. David T. Rubin presents an update on the use of vedolizumab for inflammatory bowel disease (IBD).
© 2016 Imedex, LLC.
Видео Update on vedolizumab in IBD: What have we learned? канала ImedexCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
What Else is New in IBD: Updates From the Latest Guidelines
Case Discussion: When and how to modify IBD therapies
PRO: Vedolizumab should be used before anti-TNFs for moderate to severe IBD
What IBD patients need to know about COVID-19
Recent and Emerging Ulcerative Colitis Therapies
Management of acute severe ulcerative colitis
Ulcerative Colitis: Recent and Emerging Therapies
Understanding the mechanisms of action of new agents: Implications for efficacy and safety
Debate 3: Differing perspectives on optimal timing of surgery in IBD
Keynote speaker: Understanding the monitoring and safety of IBD medications and biologics
Keynote: Evolution of Disease Management in IBD
Updates on ACG guidelines for the treatment of severe Crohn's disease
CON: Anti-TNFs should be used before Vedolizumab for moderate to severe IBD
When and how to de-escalate therapy in IBD
What is Crohn's Disease?
IBD and Pregnancy
Anthony Has Lived with Crohn’s Disease Since He Was 12
Implementing treatment pathways for the management of ulcerative colitis and Crohn's disease
IBD 2.0: Therapies 2016-2022
Medicijnen bij IBD: Vedolizumab